Genome Editing Market
Genome Editing Market - Global Industry Share, Growth, Competitive Analysis And Forecast, 2018-2023 Update Available - Forecast 2024-2030
Genome Editing is technique in which DNA is inserted, deleted, modified or replaced in the genome of a living organism. It has broad range of applications in cell line engineering, genetic engineering, plant genetic engineering, animal genetic engineering and other applications. Further, the technologies used for the genomics editing includes CRISPR-based genome editing, TALEN-based genome editing, zinc finger nucleases and other technologies. The genomics editing market is significantly growing as government is providing funding for genome editing research to various companies such as Caribou Biosciences, Inc., CRISPR Therapeutics Inc. and Editas Medicine Inc.
CRISPR/Cas systems rely upon CRISPR-associated (Cas) proteins and have the potential to carry out alter gene expression or genome editing functions. The CRISPR-Cas9 genome editing systems components can be combined in various ways for several gene editing applications. CRISPR-Cas Systems has wide application in Gene silencing, DNA-free CRISPR-Cas9 gene editing, and Homology-directed repair (HDR). CRISPR-Cas systems products include CRISPR-Cas9 Gene Editing, CRISPR Guide RNA, Cas9 Nuclease, CRISPR Controls and Detection Primers, and CRISPR-Cas9 Screening Libraries.
On the basis of geography, North America is considered to be dominating region with the highest market share and is expected to sustain its dominance during the forecast period as well. This is mainly due to the research grants and funding by government institutes and increasing genome editing application for the treatment of cancer. The key driving forces expected to boost the market of genomics editing in North America are increasing prevalence of cancer and infectious diseases and increasing trend of personalized medicine. Furthermore, Europe region is also considered to be one of major region mainly due to the presence of a large number of academic institutes and availability of funding for life science research. APAC is expected to be the fastest growing region due the government initiatives to support healthcare research and crop research initiatives in the region. The report includes detailed market overview, market segmentation, market determinants, geographical analysis, strategic recommendations, company profiling, patent analysis, key company analysis, key findings, market estimations, market insights, analyst insights and predictive analysis of the market.
Key players of genomics editing market include Exonics Therapeutics, Inc., Genscript, Horizon Discovery Group, Integrated DNA Technologies, Inc., Intellia Therapeutics, Inc., Kadmon Holdings, Inc., Lonza, Merck KGaA, New England Biolabs, Nightstar Therapeutics PLC, Origene Technologies, Inc. These market players are increasingly competing against each other by adopting different market strategies such as merger & acquisition, partnership & collaboration and so on. The research and development for innovative gene editing technology will strengthen the competitive environment of the market.
Research methods and tools
To derive the number, the market is analysed by referring annual report of each genomics editing diagnosis and treatment provider. Annual reports of the companies provide deep knowledge about the revenue in a particular region and other prospects. Furthermore, an overview of dominating and fastest growing segment market share is also derived on the basis of information provided by annual reports of the company. Beside this, geographical locations of major market player are analysed. Expansion or acquisition of manufacturing unit in a particular region has been taken into consideration for market estimation. The US, European countries, Japan, China, India and Brazil are the major location taken in to consideration.
The report covers
- Comprehensive research methodology of global genome editing market.
- In-depth analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global genome editing market.
- Insights about market determinants which are stimulating the global genome editing.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
CHAPTER 1. REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
CHAPTER 2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. ANALYST INSIGHT & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.2.2. RECOMMENDATION
2.2.3. CONCLUSION
2.3. REGULATIONS
2.3.1.1. UNITED STATES
2.3.1.2. EUROPEAN UNION
2.3.1.3. CHINA
2.3.1.4. INDIA
2.4. PATENT ANALYSIS
CHAPTER 3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. INCREASING GENOME EDITING RESEARCH AND DEVELOPMENT INITIATIVE PROGRAM
3.1.2. RISING FUNDING FOR GENOME EDITING RESEARCH
3.1.3. APPLICATION OF GENOME EDITING IN AGRICULTURE
3.1.4. INCREASING PREVALENCE OF CANCER AND INFECTIOUS DISEASES
3.1.5. INCREASING TREND OF PERSONALIZED MEDICINE
3.2. RESTRAINTS
3.2.1. HIGH COST OF GENOME EDITING INSTRUMENTS AND REAGENTS
3.2.2. LACK OF PROFESSIONAL RESEARCHER
3.2.3. TOUGH REGULATORY APPROVALS
3.3. OPPORTUNITIES
3.3.1. ADVANCEMENTS IN GENOME EDITING
3.3.2. LARGE NUMBER OF PIPELINE PRODUCTS
3.3.3. EMERGING MARKET
CHAPTER 4. MARKET SEGMENTATION
4.1. GLOBAL GENOME EDITING MARKET, BY TECHNOLOGIES
4.1.1. CRISPR-BASED GENOME EDITING
4.1.2. TALEN-BASED GENOME EDITING
4.1.3. ZINC FINGER NUCLEASES
4.1.4. OTHER (TRANSPOSONS, RECOMBINANT ADENO-ASSOCIATED VIRUS OR RAAV, HOMING ENDONUCLEASES OR MEGANUCLEASES)
4.2. GLOBAL GENOME EDITING MARKET, BY APPLICATION
4.2.1. CELL LINE ENGINEERING
4.2.2. GENETIC ENGINEERING
4.2.2.1. PLANT GENETIC ENGINEERING
4.2.2.2. ANIMAL GENETIC ENGINEERING
4.2.3. OTHER APPLICATIONS
4.3. GLOBAL GENOME EDITING MARKET BY END USERS
4.3.1. BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES
4.3.2. CONTRACT RESEARCH ORGANIZATIONS
4.3.3. RESEARCH INSTITUTES
4.3.4. OTHERS
CHAPTER 5. COMPETITIVE LANDSCAPE
5.1. KEY COMPANY ANALYSIS
5.2. KEY STRATEGIC ANALYSIS
CHAPTER 6. REGIONAL ANALYSIS
6.1. NORTH AMERICAN
6.1.1. UNITED STATES
6.1.2. CANADA
6.2. EUROPE
6.2.1. U.K
6.2.2. GERMANY
6.2.3. ITALY
6.2.4. SPAIN
6.2.5. FRANCE
6.2.6. ROE
6.3. ASIA PACIFIC
6.3.1. INDIA
6.3.2. CHINA
6.3.3. JAPAN
6.3.4. ROAPAC
6.4. REST OF THE WORLD
CHAPTER 7. COMPANY PROFILES
7.1. AGENOVIR CORP
7.2. BENCHLING, INC.
7.3. CARIBOU BIOSCIENCES, INC.
7.4. CRISPR THERAPEUTICS INC.
7.5. EDITAS MEDICINE INC.
7.6. EGENESIS BIO
7.7. EXONICS THERAPEUTICS, INC.
7.8. GENSCRIPT
7.9. HORIZON DISCOVERY GROUP
7.10. INTEGRATED DNA TECHNOLOGIES, INC.
7.11. INTELLIA THERAPEUTICS, INC.
7.12. KADMON HOLDINGS, INC.
7.13. LONZA
7.14. MERCK KGAA
7.15. NEW ENGLAND BIOLABS
7.16. NIGHTSTAR THERAPEUTICS PLC
7.17. ORIGENE TECHNOLOGIES, INC.
7.18. POSEIDA THERAPEUTICS, INC.
7.19. SANGAMO THERAPEUTICS, INC.
7.20. SYNTHEGO CORP
7.21. THERMO FISHER SCIENTIFIC, INC.
7.22. TOCAGEN, INC.
7.23. TRANSPOSAGEN BIOPHARMACEUTICALS INC.
7.24. VOYAGER THERAPEUTICS, INC.
LIST OF TABLES
TABLE # 1 GLOBAL GENOME EDITING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGIES, 2017-2023 ($ MILLION)
TABLE # 2 GLOBAL CRISPR-BASED GENOME EDITING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 3 GLOBAL TALEN-BASED GENOME EDITING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 4 GLOBAL ZINC FINGER NUCLEASES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 5 GLOBAL OTHER TECHNOLOGIES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 6 GLOBAL GENOME EDITING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2017-2023 ($ MILLION)
TABLE # 7 GLOBAL CELL LINE ENGINEERING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 8 GLOBAL GENETIC ENGINEERING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 9 GLOBAL PLANT GENETIC ENGINEERING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 10 GLOBAL ANIMAL GENETIC ENGINEERING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 11 GLOBAL OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 12 GLOBAL GENOME EDITING MARKET RESEARCH AND ANALYSIS BY END USER, 2017-2023 ($ MILLION)
TABLE # 13 GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 14 GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 15 GLOBAL RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 16 GLOBAL OTHERS END USER MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 17 GLOBAL GENOME EDITING MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023 ($ MILLION)
TABLE # 18 NORTH AMERICAN GENOME EDITING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 19 NORTH AMERICAN GENOME EDITING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGIES, 2017-2023 ($ MILLION)
TABLE # 20 NORTH AMERICAN GENOME EDITING MARKET RESEARCH AND ANALYSIS BY APPLICATION 2017-2023 ($ MILLION)
TABLE # 21 NORTH AMERICAN GENOME EDITING MARKET RESEARCH AND ANALYSIS BY END USER, 2017-2023 ($ MILLION)
TABLE # 22 EUROPEAN GENOME EDITING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 23 EUROPEAN GENOME EDITING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGIES, 2017-2023 ($ MILLION)
TABLE # 24 EUROPEAN GENOME EDITING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2017-2023 ($ MILLION)
TABLE # 25 EUROPEAN GENOME EDITING MARKET RESEARCH AND ANALYSIS BY END USER, 2017-2023 ($ MILLION)
TABLE # 26 APAC GENOME EDITING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 27 APAC GENOME EDITING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGIES, 2017-2023 ($ MILLION)
TABLE # 28 APAC GENOME EDITING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2017-2023 ($ MILLION)
TABLE # 29 APAC GENOME EDITING MARKET RESEARCH AND ANALYSIS BY END USER, 2017-2023 ($ MILLION)
TABLE # 30 ROW GENOME EDITING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGIES, 2017-2023 ($ MILLION)
TABLE # 31 ROW GENOME EDITING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2017-2023 ($ MILLION)
TABLE # 32 ROW GENOME EDITING MARKET RESEARCH AND ANALYSIS BY END USER, 2017-2023 ($ MILLION)
LIST OF FIGURES
FIGURE # 1 GLOBAL GENOME EDITING MARKET SHARE BY TECHNOLOGIES, 2017 VS 2023 (%)
FIGURE # 2 GLOBAL GENOME EDITING MARKET SHARE BY APPLICATION, 2017 VS 2023 (%)
FIGURE # 3 GLOBAL GENOME EDITING MARKET SHARE BY END USER, 2017 VS 2023 (%)
FIGURE # 4 US GENOME EDITING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 5 CANADA GENOME EDITING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 6 UK GENOME EDITING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 7 FRANCE GENOME EDITING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 8 GERMANY GENOME EDITING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 9 ITALY GENOME EDITING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 10 SPAIN GENOME EDITING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 11 ROE GENOME EDITING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 12 INDIA GENOME EDITING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 13 CHINA GENOME EDITING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 14 JAPAN GENOME EDITING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 15 ROAPAC GENOME EDITING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 16 REST OF THE WORLD GENOME EDITING MARKET SIZE, 2017-2023 ($ MILLION)
